Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults

NCT00614640 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: DermaVir patch
BIOLOGICAL: Placebo patch

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]